Variables | Univariate | Multivariate | ||||
---|---|---|---|---|---|---|
HR | 95% CI | P | HR | 95% CI | P | |
Male gender | 0.89 | 0.64–1.24 | 0.49 | |||
Age | 0.99 | 0.98–1 | 0.13 | |||
Cancer type | ||||||
Haematological malignancy | 1 | (Reference) | 0.91 | |||
Solid tumour | 0.91 | 0.65–1.28 | ||||
Cancer stage | ||||||
Complete remission | 1 | (Reference) | 0.02 | 1 | (Reference) | 0.03 |
Diagnosis | 1.37 | 0.87–2.16 | 1.44 | 0.88–2.35 | ||
Partial remission | 0.82 | 0.50–1.33 | 0.98 | 0.57–1.68 | ||
Evolutive | 1.54 | 0.99–2.41 | 1.77 | 1.10–2.87 | ||
HSCT | 1.28 | 0.86–1.92 | 0.23 | |||
Admission purpose | ||||||
Others | 1 | (Reference) | 0.055 | |||
Septic shock | 0.96 | 0.54–1.71 | ||||
Acute respiratory failure | 0.62 | 0.34–1.11 | ||||
Coma | 0.66 | 0.31–1.43 | ||||
Clinical sepsis upon admission | ||||||
None | 1 | (Reference) | 0.02 | 1 | (Reference) | 0.04 |
Respiratory | 1.67 | 1.09–2.56 | 1.65 | 1.03–2.65 | ||
Non-respiratory | 1.91 | 1.16–3.15 | 1.78 | 1.01–3.15 | ||
Characteristics upon admission | ||||||
Neutropenia | 1.41 | 1.02–1.94 | 0.04 | |||
Antibiotherapy | 1.18 | 0.80–1.72 | 0.4 | |||
Corticosteroids (curative) | 1.03 | 0.73–1.45 | 0.89 | |||
SOFA score (day of intubation) | 1.10 | 1.06–1.15 | 0.0001 | 1.11 | 1.05–1.17 | 0.0002 |
Characteristics at the first 48 h of MV | ||||||
Vasopressors | 1.34 | 0.93–1.94 | 0.11 | |||
Renal replacement therapy | 1.45 | 1.00–2.12 | 0.06 | |||
Substitutive hydrocortisone | 1.28 | 0.92–1.77 | 0.28 | |||
G-CSF | 1.85 | 1.23–2.78 | 0.005 | 1.65 | 1.03–2.65 | 0.042 |
Enteral nutrition | 1.17 | 0.68–2.00 | 0.58 | |||
Antibiotherapy | ||||||
Adapted, n (%) | 1 | (Reference) | 0.83 | |||
Empirical, n (%) | 0.85 | 0.6–1.22 | ||||
None, n (%) | 0.96 | 0.5–1.86 | ||||
VAP | 1.41 | 0.98–2.03 | 0.06 | 1.60 | 1.10–2.34 | 0.017 |